Introduction {#sec1}
============

Tuberculosis (TB) remains a serious global health concern. In 2017, World Health Organization (WHO) estimated that approximately 10.4 million new TB cases were diagnosed and 1.7 million died from it, majorly in developing countries \[[@B1]\]. Almost one-third of the population is infected with *Mycobacterium tuberculosis* (*M. TB*), however, only 10% of them develop active TB, indicating that there are discrepancies among individuals in the susceptibility to TB development. In addition to environmental factors, host genetic factors also play an important role in TB vulnerability \[[@B2]\]. Studies of *M. TB* infections in both humans and mice have reported several potential TB causal genes, including genes related to toll-like receptor (TLR) signaling \[[@B3]\].

The innate immune system activated by pathogenic bacteria acts as the first-line host defense mechanism, which recognizes and phagocytizes the invading pathogen \[[@B4]\]. The TLRs are pattern recognition receptors participants in this innate immune recognition of pathogens and stimulate the response to adaptive immune. TLR are transmembrane proteins comprising ten receptors (TLR1--10), with functions of binding ligands on cell surfaces and in the cytosolic compartment \[[@B5]\]. *M. TB* is initially discerned by TLR2 and TLR4, which subsequently interact with toll interacting protein (TOLLIP) to activate macrophages \[[@B6]\].

Because TLRs are involved in the activation of the inflammatory cytokine signaling pathways and the response to adaptive immune, they have become biologically causal genes in studies of TB \[[@B9],[@B10]\]. Our published studies demonstrated that *TLR1* and *TLR9* were associated with TB \[[@B11],[@B12]\]. Other studies from various populations reported that different TLR pathway genes, including *TLR2* \[[@B13]\], *TLR4* \[[@B13]\] and *TOLLIP* \[[@B6]\], activate the cellular immune response and might affect individual susceptibility to TB. Although numerous studies have been conducted to research the association between single nucleotide polymorphisms (SNPs) of *TLR2, TLR4*, and *TOLLIP* and TB susceptibility, the results have not been replicated among different populations.

In the present study, we used alleles, genotypes and different genetic models to evaluate whether the functional SNPs in *TLR2, TLR4* and *TOLLIP* could contribute to TB susceptibility. We performed this genotyping analysis in two independent studies in TB patients and TB-negative controls.

Materials and methods {#sec2}
=====================

Cases and controls {#sec2-1}
------------------

In the initial study, we recruited a total of 636 TB cases and 608 TB-negative controls from West China Hospital of Sichuan University. To validate the results of the initial study, we performed an independent study on 613 TB patients and 603 healthy individuals from the People's Hospital of Aba Tibetan Autonomous Prefecture. The diagnosis of TB was established according to the WHO criteria. Briefly, TB was diagnosed with a combination of radiological evidence, clinical symptoms, bacteriological investigations and response to anti-TB therapy. As control groups, we recruited individuals based on the absence of any evidence or history of TB. All participants in both initial and validated studies with immune disorders, diabetes, immune-related diseases, and HIV infection were excluded. Also, they have no blood relationship. Written informed consent was required for each participant, and 2--5 ml peripheral blood was collected in EDTA tubes and stored at −80°C until DNA extraction and genotyping. The Ethics Committees of the West China Hospital of Sichuan University and the People's Hospital of the Aba Tibetan Autonomous Prefecture provided approval for the present study.

SNPs selection and genotyping {#sec2-2}
-----------------------------

Genomic DNA was obtained from the whole blood sample according to the manufacturer's instructions (Axygen Scientific Inc, Union City, CA, U.S.A.). Potentially functional SNPs were selected based on previously reported functional effects, and *in silico* functional prediction from the FuncPred (<http://snpinfo.niehs.nih.gov/snpinfo/snpfunc.htm>). Genotyping was done by the improved multiplex ligase detection reaction (iMLDR) (Cat\#: G0104, Genesky Biotechnologies Inc., Shanghai, China) as described previously \[[@B14]\]. For quality control, 5% of the randomly selected subjects were repeated by iMLDR to confirm the genotyping results.

Statistical analysis {#sec2-3}
--------------------

Sex distribution between the cases and controls were calculated by using χ^2^ test. Fisher's exact test was used to evaluate the Hardy--Weinberg equilibrium (HWE) of the control groups. Continuous variable (shown with mean ± SD) was calculated by Student's *t* test. SHEsis online software platform (<http://analysis.bio-x.cn>) was used to calculate haplotype and linkage disequilibrium (LD) (using r^2^ as coefficients) between SNPs. The association between genotype/genetic model and TB was examined using a logistic regression analysis adjusted by sex and age. *P*-values \<0.05 were considered to be statistically significant for all tests. All analyses were conducted by SPSS version 19 (IBM, Armonk, NY).

Results {#sec3}
=======

Demographics of the participants and results of quality control {#sec3-1}
---------------------------------------------------------------

The clinical characteristics of the two studies are summarized in [Table 1](#T1){ref-type="table"}. A total of 636 TB cases and 608 TB-negative controls were recruited from the Chinese Han population for genetic analysis. There was no significant difference in either age or sex distributions between the cases (mean age: 36.8 ± 15.7 years, sex: 324 males and 312 females) and controls (mean age: 37.1 ± 15.7 years, sex: 302 males and 306 females). In the validated study, we enrolled 613 cases and 603 controls from Chinese Tibetan population. Also, the age and sex distributions in this cohort between the patients (mean age: 34.5 ± 14.5 years, sex: 327 males and 286 females) and controls (mean age: 34.6 ± 13.8 years, sex: 333 males and 270 females) were not significantly different. Briefly, the cases and controls were well matched for age and sex in the two studies.

###### Demographic distribution of TB-negative controls and TB patients

  Parameters                                                  Cases         Controls      *P*-value
  ----------------------------------------------------------- ------------- ------------- -----------
  Han population                                              *n*=636       *n*=608       
  Age, (years)[\*](#T1TFN1){ref-type="table-fn"}              36.8 ± 15.7   37.1 ± 15.7   0.677
  Male, *n* (%)                                               324 (50.9%)   302 (49.7%)   0.654
  Location of TB, *n* (PTB/EPTB)                              276/360                     
  Acid-fast bacilli stain positive, *n* (positive/negative)   138/360                     
  Culture positive *n* (positive/negative)                    32/126                      
  TB-DNA positive *n* (positive/negative)                     122/133                     
  Tibetan population                                          *n*=613       *n*=603       
  Age, (years)[\*](#T1TFN1){ref-type="table-fn"}              34.5 ± 14.5   34.6 ± 13.8   0.909
  Male, *n* (%)                                               327 (53.3%)   333 (55.2%)   0.511

Abbreviations: EPTB, extra-pulmonary TB PTB, pulmonary TB; SD, standard deviation.

Data are presented as mean ± SD.

Polymorphisms of the three genes in the two studies {#sec3-2}
---------------------------------------------------

According to literature review and FuncPred, four SNPs (rs1898830, rs3804099, rs3804100 and rs5743708) in *TLR2*, four SNPs (rs10759932, rs12377632, rs11536889 and rs7873784) in *TLR4* and three SNPs (rs3750920, rs5743899 and rs5743867) in *TOLLIP* were retained for analysis ([Table 2](#T2){ref-type="table"}). None of the SNPs deviated from HWE.

###### Basic information of all SNPs in our study

  Gene/SNPs    Chromosome   Location    Functional consequence   MA   MAF     MA   MAF     HWE     
  ------------ ------------ ----------- ------------------------ ---- ------- ---- ------- ------- -------
  *TLR2*                                                                                           
  rs1898830    4            154608453   intron1                  G    0.406   G    0.461   0.839   0.456
  rs3804099    4            154624656   synon_exon3              C    0.303   C    0.224   0.830   0.575
  rs3804100    4            154625409   synon_exon3              C    0.260   C    0.204   0.985   0.963
  rs5743708    4            154626317   nonsynon_exon3           A    0.000   A    0.000   \-      \-
  *TLR4*                                                                                           
  rs10759932   9            120465144   5′Flanking               C    0.263   C    0.325   0.608   0.830
  rs12377632   9            120472730   intron3                  T    0.387   T    0.436   0.996   0.828
  rs11536889   9            120478131   3′UTR_exon4              C    0.245   C    0.155   0.563   0.748
  rs7873784    9            120478936   3′UTR_exon4              C    0.084   C    0.066   0.934   0.690
  *TOLLIP*                                                                                         
  rs3750920    11           1309956     synon_exon4              T    0.309   T    0.285   0.751   0.100
  rs5743899    11           1323564     intron1                  C    0.374   C    0.365   0.824   0.870
  rs5743867    11           1328351     intron1                  G    0.365   G    0.356   0.652   0.797

Abbreviations: MA, minor allele; MAF, MA frequency.

The genotypic and allelic frequencies of the two studies are shown in [Table 3](#T3){ref-type="table"}; genetic models are shown in [Table 4](#T4){ref-type="table"}. In the initial Chinese Han population, the frequency of *TLR2* rs1898830 G allele was lower in TB patients than in controls (*P* = 0.035, odds ratio (OR) = 0.84, 95% confidence interval (CI): 0.72--0.99), indicating it was a protective factor against TB. We also found rs1898830 GG genotype was associated with decreased risk for TB development (*P*=0.042, OR = 0.72, 95% CI: 0.52--0.99). For rs5743708, all participants were detected to be monomorphic except for two patients with GA heterozygote. There was no statistical significance in allelic or genotypic frequencies between cases and controls for *TLR4* and *TOLLIP* in this cohort. Three haplotypes in *TLR2* showed a value of *P*\<0.05, e.g., ACTG (*P*=0.025), ATTG (*P*=0.048) and GTTG (*P*=0.035) ([Table 5](#T5){ref-type="table"}). However, the sites rs3804099 and rs3804100 of TLR2 were in high LD, and rs5743899 and rs5743867 of *TOLLIP* also were in high LD (r^2^ \> 0.8) ([Figure 1](#F1){ref-type="fig"}).

![LD of *TLR2, TLR4* and *TOLLIP* gene polymorphisms in the both Han (above) and Tibetan (down) populations\
LD r^2^ values (range from 0 to 1) for all pairs of SNPs are presented as percentages. Shading from white to black indicates LD measured as r^2^ (range from 0 to 1).](bsr-40-bsr20193141-g1){#F1}

###### Genotype distribution of *TLR2, TLR4* and *TOLLIP* in the two populations

                          Han population   Tibetan population                                                                   
  ------------ ---------- ---------------- -------------------- ------- ------------------- ------------- ------------- ------- -------------------
  *TLR2*                                                                                                                        
  rs1898830    Genotype                                                                                                         
               AA         227 (25.9)       188 (31.1)                                       191 (31.2)    152 (25.2)            
               GA         297 (47.0)       292 (48.3)           0.193   0.85 (0.66--1.09)   279 (45.5)    316 (52.4)    0.009   0.70 (0.54--0.92)
               GG         108 (17.7)       125 (20.7)           0.042   0.72 (0.52--0.99)   143 (23.3)    135 (22.4)    0.307   0.85 (0.62--1.17)
               Allele                                                                                                           
               A          751 (59.4)       668 (55.2)                                       661 (53.9)    620 (51.4)            
               G          513 (40.6)       542 (44.8)           0.035   0.84 (0.72--0.99)   565 (46.1)    586 (48.6)    0.229   0.91 (0.77--1.06)
  rs3804099    Genotype                                                                                                         
               TT         313 (49.5)       294 (48.6)                                       374 (61.0)    357 (59.3)            
               CT         255 (40.3)       260 (43.0)           0.505   0.92 (0.73--1.17)   203 (33.1)    219 (36.4)    0.291   0.88 (0.69--1.12)
               CC         64 (10.1)        51 (8.4)             0.457   1.17 (0.78--1.74)   36 (5.9)      26 (4.3)      0.302   1.32 (0.78--2.23)
               Allele                                                                                                           
               T          881 (69.7)       848 (70.1)                                       951 (77.6)    933 (77.5)            
               C          383 (30.3)       362 (29.9)           0.826   1.02 (0.86--1.21)   275 (22.4)    271 (22.5)    0.951   0.99 (0.82--1.20)
  rs3804100    Genotype                                                                                                         
               TT         331 (52.6)       330 (54.6)                                       387 (63.1)    381 (63.2)            
               CT         247 (39.3)       234 (38.7)           0.654   1.06 (0.83--1.34)   196 (32.0)    198 (32.8)    0.804   0.97 (0.76--1.24)
               CC         51 (8.1)         40 (6.6)             0.241   1.30 (0.84--2.00)   30 (4.9)      24 (4.0)      0.501   1.21 (0.69--2.11)
               Allele                                                                                                           
               T          909 (72.3)       894 (74.0)                                       970 (79.1)    960 (79.6)            
               C          349 (27.7)       314 (26.0)           0.267   1.11 (0.93--1.32)   256 (20.9)    246 (20.4)    0.785   1.03 (0.84--1.25)
  rs5743708    Genotype                                                                                                         
               GG         629 (99.7)       605 (1.0)                                        613 (1.0)     601 (99.7)            
               GA         2 (0.3)          0 (0.0)              \-                          0 (0.0)       2 (0.3)       \-      
               AA         0 (0.0)          0 (0.0)              \-                          0 (0.0)       0 (0.0)       \-      
               Allele                                                                                                           
               G          1260 (99.8)      1210 (1.0)                                       1226 (1.0)    1204 (99.8)           
               A          2 (0.2)          0 (0.0)              \-                          0 (0.0)       2 (0.2)       \-      
  *TLR4*                                                                                                                        
  rs10759932   Genotype                                                                                                         
               TT         347 (54.9)       322 (53.2)                                       256 (41.8)    278 (46.1)            
               CT         238 (37.7)       232 (38.3)           0.628   0.94 (0.74--1.20)   277 (45.2)    258 (42.8)    0.193   1.17 (0.92--1.49)
               CC         47 (7.4)         51 (8.4)             0.499   0.46 (0.57--1.32)   80 (13.1)     67 (11.1)     0.176   1.29 (0.89--1.86)
               Allele                                                                                                           
               T          932 (73.7)       876 (72.4)                                       789 (64.4)    814 (67.5)            
               C          332 (26.3)       334 (27.6)           0.433   0.93 (0.78--1.11)   437 (35.6)    392 (32.5)    0.098   1.15 (0.97--1.36)
  rs12377632   Genotype                                                                                                         
               CC         232 (36.7)       227 (37.5)                                       178 (29.0)    188 (31.2)            
               CT         304 (48.1)       288 (47.6)           0.808   1.03 (0.81--1.31)   316 (51.5)    304 (50.4)    0.473   1.10 (0.85--1.42)
               TT         96 (15.2)        90 (14.9)            0.797   1.05 (0.74--1.47)   119 (19.4)    111 (18.4)    0.460   1.13 (0.81--1.58)
               Allele                                                                                                           
               C          768 (60.8)       742 (61.3)                                       672 (54.8)    680 (56.4)            
               T          496 (39.2)       468 (38.7)           0.785   1.02 (0.87--1.20)   554 (45.2)    526 (43.6)    0.429   1.07 (0.91--1.25)
  rs11536889   Genotype                                                                                                         
               GG         361 (57.1)       339 (56.0)                                       436 (71.1)    387 (64.3)            
               GC         232 (36.7)       221 (36.5)           0.911   0.99 (0.78--1.25)   164 (26.8)    195 (32.4)    0.021   0.75 (0.58--0.96)
               CC         39 (6.2)         45 (7.4)             0.358   0.81 (0.51--1.27)   13 (2.1)      20 (3.3)      0.129   0.58 (0.28--1.18)
               Allele                                                                                                           
               G          954 (75.5)       899 (74.3)                                       1036 (84.5)   969 (80.5)            
               C          310 (24.5)       211 (25.7)           0.492   0.84 (0.78--1.13)   190 (15.5)    235 (19.5)    0.009   0.76 (0.61--0.93)
  rs7873784    Genotype                                                                                                         
               GG         523 (82.8)       508 (84.0)                                       534 (87.1)    516 (85.6)            
               GC         105 (16.6)       92 (15.2)            0.498   1.11 (0.82--1.51)   77 (12.6)     82 (13.6)     0.571   0.91 (0.6--1.27)
               CC         4 (0.6)          5 (0.8)              0.701   0.77 (0.21--2.90)   2(0.3)        5(0.8)        0.280   0.40 (0.08--2.10)
               Allele                                                                                                           
               G          1151 (91.1)      1108 (91.6)                                      1145 (93.4)   1114 (92.4)           
               C          113 (8.9)        102 (8.4)            0.638   1.07 (0.81--1.42)   81 (6.6)      92 (7.6)      0.335   0.86 (0.63--1.17)
  *TOLLIP*                                                                                                                      
  rs3750920    Genotype                                                                                                         
               CC         294 (46.5)       288 (47.6)                                       310 (50.6)    303 (50.2)            
               CT         286 (45.3)       253 (41.8)           0.406   1.11 (0.87--1.40)   256 (41.8)    233 (38.6)    0.556   1.07(0.85--1.36)
               TT         52 (8.2)         64 (10.6)            0.279   0.80 (0.54--1.20)   47 (7.7)      67 (11.1)     0.065   0.68 (0.45--1.02)
               Allele                                                                                                           
               C          874 (69.1)       829 (68.5)                                       876 (71.5)    839 (69.6)            
               T          390 (30.9)       381 (31.5)           0.711   0.97 (0.82--1.15)   350 (28.5)    367 (30.4)    0.302   0.91 (0.77--1.09)
  rs5743899    Genotype                                                                                                         
               TT         248 (39.2)       241 (39.8)                                       249 (40.6)    241 (40.0)            
               CT         291 (46.0)       276 (45.6)           0.850   1.02 (0.80--1.30)   280 (45.7)    275 (45.7)    0.912   0.99 (0.77--1.26)
               CC         93 (14.7)        88 (14.5)            0.873   1.03 (0.73--1.45)   84 (13.7)     86 (14.3)     0.748   0.94 (0.97--1.40)
               Allele                                                                                                           
               T          787 (62.3)       758 (62.6)                                       778 (63.5)    757 (62.9)            
               C          477 (37.7)       452 (37.4)           0.834   1.02 (0.87--1.20)   448 (36.5)    447 (37.1)    0.764   0.98 (0.83--1.15)
  rs5743867    Genotype                                                                                                         
               AA         254 (40.2)       249 (41.2)                                       256 (41.8)    249 (41.3)            
               GA         289 (45.7)       270 (44.6)           0.698   1.05 (0.8--1.34)    278 (45.4)    271 (44.9)    0.985   0.99 (0.78--1.27)
               GG         89 (14.1)        86 (14.2)            0.935   1.01 (0.72--1.43)   79 (12.9)     83 (13.8)     0.668   0.93 (0.65--1.32)
               Allele                                                                                                           
               A          797 (63.1)       768 (63.5)                                       790 (64.4)    769 (63.8)            
               G          467 (36.9)       442 (36.5)           0.817   1.02 (0.87--1.20)   436 (35.6)    437 (36.2)    0.726   0.97 (0.82--1.15)

Adjusted by age and sex status.

###### Association between genotype of *TLR2, TLR4* and *TOLLIP* and TB in the two populations

  Gene/SNPs         Han population   Tibetan population           
  ----------------- ---------------- -------------------- ------- -------------------
  *TLR2*                                                          
  rs1898830                                                       
  Dominant model    0.074            0.81 (0.94--1.02)    0.023   0.75 (0.58--0.96)
  Recessive model   0.106            0.79 (0.59--1.05)    0.680   1.06 (0.81--1.38)
  rs3804099                                                       
  Dominant model    0.752            0.97 (0.77--1.21)    0.525   0.93 (0.74--1.69)
  Recessive model   0.300            1.23 (0.83--1.81)    0.213   1.39 (0.83--2.34)
  rs3804100                                                       
  Dominant model    0.437            1.09 (0.87--1.37)    0.993   0.99 (0.79--1.26)
  Recessive model   0.243            1.29 (0.84--1.96)    0.436   1.25 (0.72--2.16)
  rs5743708                                                       
  Dominant model    \-                                    \-      
  Recessive model   \-                                    \-      
  *TLR4*                                                          
  rs10759932                                                      
  Dominant model    0.522            0.93 (0.74--1.16)    0.119   1.20 (0.96--1.50)
  Recessive model   0.521            0.87 (0.58--1.32)    0.304   1.20 (0.85--1.70)
  rs12377632                                                      
  Dominant model    0.783            1.03 (0.82--1.30)    0.408   1.11 (0.87--1.42)
  Recessive model   0.878            1.03 (0.75--1.40)    0.653   1.07 (0.80--1.42)
  rs11536889                                                      
  Dominant model    0.697            0.96 (0.76--1.20)    0.011   0.73 (0.57--0.93)
  Recessive model   0.365            0.81 (0.52--1.27)    0.204   0.63 (0.34--1.28)
  rs7873784                                                       
  Dominant model    0.440            0.88 (0.63--1.22)    0.554   1.10 (0.81--1.48)
  Recessive model   0.273            0.40 (0.77--2.07)    0.697   0.77 (0.21--2.88)
  *TOLLIP*                                                        
  rs3750920                                                       
  Dominant model    0.720            1.04 (0.83--1.30)    0.901   0.99 (0.79--1.24)
  Recessive model   0.149            0.75 (0.51--1.11)    0.040   0.66 (0.45--0.98)
  rs5743899                                                       
  Dominant model    0.828            1.03 (0.82--1.29)    0.838   0.98 (0.78--1.23)
  Recessive model   0.915            1.02 (0.74--1.40)    0.762   0.95 (0.69--1.32)
  rs5743867                                                       
  Dominant model    0.730            1.04 (0.83--1.31)    0.866   0.98 (0.78--1.23)
  Recessive model   0.965            0.99 (0.72--1.37)    0.649   0.93 (0.67--1.29)

Adjusted by sex and age.

###### Haplotype analyses in the two populations

                                            Han population   Tibetan population                                                                      
  ----------------------------------------- ---------------- -------------------- ------- ------------------- -------------- --------------- ------- -------------------
  TLR2                                                                                                                                               
  ACCG                                      342.1 (27.1)     302.4 (25.0)         0.235   1.12 (0.93--1.34)   249.0 (20.3)   238.1 (19.8)    0.817   1.02 (0.84--1.25)
  ACTG                                      27.4 (2.2)       44.7 (3.7)           0.025   0.58 (0.36--0.94)                                          
  ATTG                                      380.3 (30.1)     321.0 (26.5)         0.048   1.19 (1.00--1.42)   393.0 (32.1)   351.9 (29.2)    0.165   1.13 (0.95--1.35)
  GTTG                                      497.7 (39.4)     527.0 (43.6)         0.035   0.84 (0.72--0.99)   558.0 (45.5)   579.1 (48.1)    0.140   0.89 (0.75--1.04)
  Other[\*](#T5TFN1){ref-type="table-fn"}   14.4 (0.01)      15.0 (1.2)                                       26.0 (2.1)     34.9 (2.9)              
  TLR4                                                                                                                                               
  CTGG                                      318.4 (25.2)     320.9 (26.5)         0.429   0.93 (0.78--1.11)   417.6 (34.1)   377.9 (31.4)    0.149   1.13 (0.96--1.34)
  TCCG                                      297.9 (23.6)     304.6 (25.2)         0.335   0.91 (0.76--1.10)   188.4 (15.4)   222.9 (18.5)    0.040   0.80 (0.65--0.99)
  TCGG                                      464.5 (36.8)     424.6 (35.1)         0.410   1.07 (0.91--1.26)   464.3 (37.9)   446.8 (37.1)    0.670   1.04 (0.88--1.22)
  TTGC                                      108.3 (8.6)      93.0 (7.7)           0.433   1.12 (0.84--1.50)   70.2(5.7)      85.3 (7.1)      0.175   0.80 (0.58--1.11)
  TTGG                                      54.4 (4.3)       44.6 (3.7)           0.441   1.17 (0.78--1.76)   59.6 (4.9)     47.9 (4.0)      0.286   1.24 (0.84--1.82)
  Other[\*](#T5TFN1){ref-type="table-fn"}   20.5 (1.6)       22.3 (1.8)                                       25.9 (2.1)     23.2 (2.0)              
  TOLLIP                                                                                                                                             
  CCG                                       463.9 (36.7)     400.0 (36.4)         0.879   1.01 (0.86--1.19)   433.5 (35.4)   4345.0 (36.1)   0.705   0.97 (0.82--1.14)
  CTA                                       402.9 (31.9)     379.6 (31.4)         0.803   1.02 (0.86--1.21)   433.8 (35.4)   392.1 (32.6)    0.137   1.14 (0.96--1.35)
  TTA                                       384.1 (30.4)     376.4 (31.1)         0.682   0.97 (0.81--1.15)   343.2 (28.0)   362.9 (30.1)    0.250   0.90 (0.76--1.08)
  Other[\*](#T5TFN1){ref-type="table-fn"}   13.1 (1.0)       14.1 (1.2)                                       15.6 (1.2)     14.1 (1.2)              

Those with lowest frequency threshold (LFT) \< 0.03 were pooled in this part.

In the validated Chinese Tibetan study, *TLR2* rs1898830 polymorphism was associated with decreased risk for TB, which was in accordance with the result of the initial study. Compared with AA genotype, both the GA (*P*=0.009, OR = 0.70, 95% CI: 0.54--0.92) and GG+GA (*P*=0.023, OR = 0.75, 95% CI: 0.58--0.96) were found to be protective factors against TB susceptibility. For *TLR4*, the frequencies of rs11536889 C allele (*P*=0.009, OR = 0.76, 95% CI: 0.61--0.93) and GC genotype (*P*=0.021, OR = 0.75, 95% CI: 0.58--0.96) were higher in controls as compared with TB cases. We also found the rs11536889 CC+GC to be a significant protective factor against TB under a dominant model (*P*=0.011, OR = 0.73, 95% CI: 0.57--0.93). For *TOLLIP*, only the rs3750920 site was found to be associated with the occurrence of TB in the recessive model (*P*=0.040, OR = 0.66, 95% CI: 0.45--0.98). Haplotype analysis revealed that *TLR4* TCCG haplotype was associated with TB (*P*=0.040, OR = 0.80, 95% CI: 0.65--0.99) ([Table 5](#T5){ref-type="table"}). High LD (r^2^ \> 0.8) was found between the two *TLR2* loci (rs3804099 and rs3804100) and two *TOLLIP* loci (rs5743899 and rs5743867) ([Figure 1](#F1){ref-type="fig"}).

Discussion {#sec4}
==========

Accumulated studies have demonstrated that *TLR2, TLR4* and *TOLLIP* are pivotal mediators of individual response to and etiology of various pathogens causing common human diseases, including TB. In this self-validating association study, we researched the impact of functional SNPs in *TLR2, TLR4* and *TOLLIP* and TB in two independent cohorts. Our findings revealed that *TLR2* polymorphism was associated with TB development in the Chinese Han population, which was validated in the Tibetan study. We also observed that TLR4 and TOLLIP genetic variants were protective factors against TB in the Tibetan population, but not in the Han population.

Although microbe exposure and environmental factors play important roles in TB development, there is convincing evidence regarding the causal gene of TB susceptibility \[[@B11],[@B12],[@B15],[@B16]\]. TLRs family members are important to defend against *M. TB* infection. TLR2, as a family member of TLRs, could activate an immunoreaction against *M. TB* via recognizing *M. TB* components and shaping pro-inflammatory signals \[[@B17]\]. Abundant studies proposed that *TLR2* polymorphisms were involved in bacterial infections and various diseases \[[@B15],[@B18]\]. In the present study, the allele or genotype distribution of rs1898830 strongly differed between TB cases and controls in the initial cohort and it was replicated in the Tibetan sample. One study has reported that rs1898830 GG was related to low *FOXP3, GITR* and *LAG3* expression in cord blood mononuclear cells and it also can reduce the T helper 2 cell and tumor necrosis factor secretion \[[@B21]\]. Combined with the above aspects, the *TLR2* rs1898830 polymorphism might be a causative factor for TB susceptibility. Previous studies have demonstrated that rs3804099, rs3804100 and rs5743708 were associated with TB in different populations \[[@B22]\], with inconsistent results. Xue et al. demonstrated that rs3804099 and rs3804100 were associated with pulmonary TB in the Tibetan population \[[@B24]\]. Also, another similar study with regard to Chinese Han found the two SNPs were not related to TB \[[@B16]\]. Our result was the same as the latter study. In addition, we validated the recent findings by Sánchez et al. in terms of no association between rs5743708 and TB \[[@B26]\].

The TLR4 is important in the activation of nuclear factor-κB by signal transduction related to different intracellular signaling systems and some inflammatory cytokines levels \[[@B27],[@B28]\]. In addition, the TLR4 signaling pathway is known to maintain the balance between necrotic and apoptotic cell death caused by macrophages infected with *M. TB* \[[@B29]\]*.* Previous data have suggested that TLR4 mutant mice were more likely to be infected with *M. TB* \[[@B30]\]. In our research, the rs11536889 showed the strongest association with TB in the Tibetan population but not in the Chinese Han population, in agreement with another study aimed to detect such an SNP and TB in the Tibetan population \[[@B31]\] with the same CC+GC protective genotype. It was suggested that rs11536889 was a functional SNP, and it can influence not only the translational regulation of TLR4 expression and the post-transcriptional regulation \[[@B32]\]. Furthermore, this functional polymorphism was found to be associated with many infections and diseases, including rheumatoid arthritis \[[@B33]\], periodontitis \[[@B34]\] and sepsis \[[@B31]\].

TOLLIP has been previously described as a regulator of the interleukin-1 receptor pathway \[[@B35]\]. It can also directly interact with TLR2 and induce the phosphorylation and kinase activity of IRAK1 and thus stimulates termination of TLR2 signaling \[[@B36]\]. Interestingly, *TOLLIP* polymorphisms and its interaction with TLR2 and TLR4 in human monocytes were related to TB susceptibility \[[@B6]\]. *TOLLIP* rs3750920 is encoded on chromosome 11p15.5 and located in the fourth exon. Shah et al. demonstrated that the minor homozygote TT of rs3750920 was significantly associated with elevated mRNA expression, resulting in decreased risk against TB \[[@B6]\]. Consistent with this functional genotype, our study showed that TT genotype, compared with CC+CC, was associated with TB protection in the Tibetan population. However, we did not find this association in the initial study. A similar study conducted in Kampala, Uganda, gave results that showed significance between the risk of TB and *TOLLIP* rs5743867 polymorphism. We did not validate these findings in both Chinese Han and Tibetan populations. Although our study design was similar to the Shah et al., collecting patients' peripheral blood, using a case--control study method, our result regarding rs5743899 was inconsistent with Shah et al. who found that this locus was associated with TB susceptibility. The discrepancies between the aforementioned results may be attributed to the different sample sizes and ethnicities \[[@B37]\]. Our results were also differing from our previous study \[[@B38]\], which demonstrated that polymorphisms in *TOLLIP* affected the risk of pulmonary TB. The different results may be due to the different study designs.

Conclusion {#sec5}
==========

In conclusion, our results demonstrated that the polymorphism of rs1898830 in *TLR2* was associated with TB susceptibility in both Chinese Han and Tibetan populations. Also, we found associations between rs11536889 in *TLR4* and rs3750920 in *TOLLIP* with TB in the Tibetan population, but not in the Han population. Further studies are needed to reveal the potential mechanisms of the involvement of these genes in the development of TB.
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HWE
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M. TB

:   *Mycobacterium tuberculosis*
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